Related Experiment Video
Updated: Jun 24, 2026
08:27
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
Highly sensitive detection of melanoma based on serum proteomic profiling
Julie Caron1, Alain Mangé, Bernard Guillot
1Department of Dermatology, CHU Montpellier, Hôpital Saint Eloi, Montpellier, France.
Journal of Cancer Research and Clinical Oncology
|March 17, 2009
Summary
Serum proteomic profiling shows promise for detecting melanoma. This novel approach accurately identifies melanoma patients, including early-stage cases, using a multiprotein classifier.
Area of Science:
- Biochemistry
- Oncology
- Proteomics
Background:
- Primary melanoma lacks a reliable tumor marker for early detection.
- Proteomics analysis offers a novel approach for discovering potential melanoma biomarkers.
Purpose of the Study:
- To investigate the utility of serum proteomic fingerprinting for discriminating melanoma from healthy individuals.
- To develop a classifier for accurate melanoma diagnosis and staging.
Main Methods:
- Utilized surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) on 108 serum samples (melanoma patients and healthy volunteers).
- Employed artificial neural networks for classification, analyzing proteomic profiles.
- Developed and validated a multiprotein classifier using training and independent test sets.
Main Results:
- The multiprotein classifier achieved high diagnostic accuracy (98.1%) in an independent validation set.
- Demonstrated excellent sensitivity (96.7%) and specificity (100%) for melanoma detection.
- Achieved 100% accuracy in assigning early-stage (I/II) melanoma classification.
Conclusions:
- Serum proteomic profiling is a valuable tool for sensitive and specific melanoma detection.
- This method can identify melanoma, including non-metastatic cases, from serum samples.
- Further validation in larger patient cohorts is warranted to confirm these findings.
